These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20837122)

  • 1. Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity.
    Jain A; Yan W; Miller KR; O'Carra R; Woodward JG; Mumper RJ
    Int J Pharm; 2010 Nov; 401(1-2):87-92. PubMed ID: 20837122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-conjugated N-trimethylaminoethylmethacrylate chitosan nanoparticles induce strong immune responses after nasal administration.
    Liu Q; Zheng X; Zhang C; Shao X; Zhang X; Zhang Q; Jiang X
    Pharm Res; 2015 Jan; 32(1):22-36. PubMed ID: 24970313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
    Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM
    Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
    Slütter B; Soema PC; Ding Z; Verheul R; Hennink W; Jiskoot W
    J Control Release; 2010 Apr; 143(2):207-14. PubMed ID: 20074597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of nickel nanoparticles for binding to his-tag proteins and antigens.
    Patel JD; O'Carra R; Jones J; Woodward JG; Mumper RJ
    Pharm Res; 2007 Feb; 24(2):343-52. PubMed ID: 17180725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
    Slütter B; Bal SM; Que I; Kaijzel E; Löwik C; Bouwstra J; Jiskoot W
    Mol Pharm; 2010 Dec; 7(6):2207-15. PubMed ID: 21043518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lignin nanoparticles as a promising vaccine adjuvant and delivery system for ovalbumin.
    Alqahtani MS; Kazi M; Ahmad MZ; Syed R; Alsenaidy MA; Albraiki SA
    Int J Biol Macromol; 2020 Nov; 163():1314-1322. PubMed ID: 32645499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly stable gold nanoparticle-antigen conjugates with self-adjuvanting property for induction of robust antigen-specific immune responses.
    Lin ZY; Chen YH; Wu YW; Chen MC
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112897. PubMed ID: 36215893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel vaccine delivery system based on Gantrez nanoparticles.
    Gómez S; Gamazo C; San Roman B; Vauthier C; Ferrer M; Irachel JM
    J Nanosci Nanotechnol; 2006; 6(9-10):3283-9. PubMed ID: 17048548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 13. Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies.
    Courant T; Bayon E; Reynaud-Dougier HL; Villiers C; Menneteau M; Marche PN; Navarro FP
    Biomaterials; 2017 Aug; 136():29-42. PubMed ID: 28511142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of Modified Konjac Glucomannan Nanoparticles and their Application as Vaccine Adjuvants to Promote Ovalbumin-Induced Immune Response in Mice.
    Chen N; Zhu P; Du T; Han K; Wang D; Ye J; Xiao S; Ye X; Wang Y
    Pharm Res; 2018 Mar; 35(5):105. PubMed ID: 29560565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
    Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
    J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-step conjugation of bioactive peptides to proteins via a self-contained succinimidyl bis-arylhydrazone.
    Phillips JA; Morgan EL; Dong Y; Cole GT; McMahan C; Hung CY; Sanderson SD
    Bioconjug Chem; 2009 Oct; 20(10):1950-7. PubMed ID: 19788175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens.
    Yanasarn N; Sloat BR; Cui Z
    Mol Pharm; 2011 Aug; 8(4):1174-85. PubMed ID: 21615153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
    Mittal A; Raber AS; Schaefer UF; Weissmann S; Ebensen T; Schulze K; Guzmán CA; Lehr CM; Hansen S
    Vaccine; 2013 Jul; 31(34):3442-51. PubMed ID: 23290836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization of archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) formulations prepared by different protocols and their efficacy upon intranasal immunization of mice.
    Patel GB; Ponce A; Zhou H; Chen W
    J Liposome Res; 2008; 18(2):127-43. PubMed ID: 18569448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice.
    Howe SE; Konjufca VH
    PLoS One; 2015; 10(2):e0118067. PubMed ID: 25710518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.